Stay updated with breaking news from Apollo Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today presented early data for its self-expanding Intrepid™ transcatheter...
Transfemoral access added into landmark APOLLO Pivotal Trial following IDE approval from FDA - Medtronic plc a global leader in healthcare technology, today presented early data for its self-expanding Intrepid ™ transcatheter mitral valve replacement system in patients with severe, symptomatic mitral valve regurgitation utilizing the transfemoral access route. Presented as Late-Breaking Clinical Science at the ...
/PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today presented early data for its self-expanding Intrepid™ transcatheter...